🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the clinical efficacy of blisibimo...
Status
Withdrawn
Location
Multiple Locations
Start Date
2015-12
Trial ID
NCT02074020
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of subcuta...
Status
Completed
Location
Investigator Site 852
Start Date
2013-06
Trial ID
NCT02062684
Treatments Being Tested
The purpose of this study is to evaluate efficacy, safety and tolerability ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2015-12
Trial ID
NCT01609452
Treatments Being Tested
The purpose of this study is to evaluate the efficacy, safety and tolerabil...
Status
Completed
Location
Investigator Site 103
Start Date
2010-07
Trial ID
NCT01162681
Treatments Being Tested
The purpose of this study is to evaluate the clinical efficacy of blisibimo...
Status
Terminated
Location
Investigator Site 004
Start Date
2016-06
Trial ID
NCT02514967
Treatments Being Tested
The purpose of this study is to evaluate the long-term safety of A-623 in s...
Status
Completed
Location
Investigator Site 103
Start Date
2011-04
Trial ID
NCT01305746
The purpose of this study is to evaluate efficacy, safety and tolerability ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2014-12
Trial ID
NCT01598857
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of subcuta...
Status
Completed
Location
Investigator Site 603
Start Date
2013-02
Trial ID
NCT01395745
Treatments Being Tested
The purpose of this study is to compare the effect of blisibimod plus stand...
Status
Withdrawn
Location
Multiple Locations
Start Date
2014-10
Trial ID
NCT02052219
Treatments Being Tested